Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Naturally arising CD25(+)CD4(+) regulatory T cells actively maintain immunological self-tolerance. Deficiency in or dysfunction of these cells can be a cause of autoimmune disease. A reduction in their number or function can also elicit tumor immunity, whereas their antigen-specific population expansion can establish transplantation tolerance. They are therefore a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence has shown that Treg cells are recruited into the TME and behave as powerful immunosuppressors.61, 62”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [62]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“In addition, they specifically express Foxp3 , which encodes a transcription factor, as a key control gene in their development and functio”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Self-citationThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“The fact that many tumor-associated antigens recognized by autologous T cells in cancer patients are antigenically normal self constituents indicates that natural CD25 + CD4 + T reg cells engaged in the maintenance of self-tolerance may concomitantly impede immunosurveillance against autologous tumor cell”
BackgroundTivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Research works printed but not linked: 1
- Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. A crucial role of IL-2 in the homeostatic maintenance of CD25+CD4+ regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press).
Cited by
Items 901–1,000 of 1,010
McGee, H. S., & Agrawal, D. K. (2006) · Immunologic Research · doi:10.1385/ir:35:3:219 · Cited by 64
“Although autoreactive T cells are normally present in all individuals, clinical disease only affects a minority population, suggesting that mechanisms for peripheral self-tolerance must exist to completely control pathogenic T cells ( 3 ).”
BackgroundVojdani, A., & Erde, J. (2006) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nel047 · Cited by 57
“These cells were infused into skin graft recipient mice, preventing skin graft rejection even though the mice were also infused with NK and T cells (68,69).”
BackgroundUnraveling resistance to immunotherapy in MSI-high colorectal cancer
Heregger, R., Huemer, F., Steiner, M., Gonzalez-Martinez, A., Greil, R., & Weiss, L. (2023) · Cancers · doi:10.3390/cancers15205090 · Cited by 52
“Tregs play a key role in maintaining immune homeostasis by limiting the inflammation caused by effector T cells [15,16].”
BackgroundAnti-inflammatory Effects of Exercise
Gleeson, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_16 · Cited by 54
Impaired Balance of Th17/Treg in Patients with Nasal Polyposis
Shen, Y., Tang, X. ‐., Yang, Y. ‐., Xia, K., Kou, W., Pan, C.-K., & Hong, S. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02546.x · Cited by 55
Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction
Niu, J., Jiang, C., Li, C., Liu, L., Li, K., Jian, Z., & Gao, T. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1025-3 · Cited by 55
“The importance of Tregs lies in their pivotal role in maintaining immunologic tolerance and preventing autoimmune diseases [2, 3].”
BackgroundPicca, C. C., Simons, D. M., Oh, S. A., Aitken, M., Perng, O. A., Mergenthaler, C., Kropf, E., Erikson, J., & Caton, A. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103810108 · Cited by 56
“However, it has also become clear that thymocytes can undergo selection to become CD4CD25Foxp3 regulatory T (Treg) cells (8, 9), and how signaling through the TCR induces the formation of Treg cells is not yet understood.”
McGee, H. S., Yagita∥, H., Shao, Z., & Agrawal, D. K. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0258oc · Cited by 55
Wang, F., Jing, X., Li, G., Wang, T., Yang, B., Zhu, Z., Gao, Y., Zhang, Q., Yang, Y., Wang, Y., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02675.x · Cited by 55
“Based on the definition of the phenotype and function of Tregs in mice (10, 11), the presence of Tregs in human autoimmune diseases, inflammation and cancer research has been investigated.”
BackgroundCancer treatment: the combination of vaccination with other therapies
Andersen, M. H., Sørensen, R. B., Schrama, D., Svane, I. M., Becker, J. C., & Straten, P. T. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0480-y · Cited by 61
“In lack of suYcient evidence for the presence of such cells the concept was abandoned [60].”
BackgroundIncreased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling
Ordoñez‐Rueda, D., Lozano, F., Sarukhan, A., Raman, C., García-Zepeda, E. A., & Soldevila, G. (2009) · European Journal of Immunology · doi:10.1002/eji.200839053 · Cited by 65
Dendritic cells: tools and targets for antitumor vaccination
den Brok, M. H., Nierkens, S., Figdor, C. G., Ruers, T. J. M., & Adema, G. J. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.5.699 · Cited by 58
T cell populations propagating in the peripheral blood of patients with drug eruptions
Nishio, D., Izu, K., Kabashima, K., & TOKURA, Y. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.05.013 · Cited by 52
“On the other hands, a subset of CD4 T cells bearing CD25 has been well characterized as regulatory T cells (Treg) that suppress the effector functions of CD4 and CD8 cells [15].”
BackgroundKreijveld, E., Koenen, H. J. P. M., van Cranenbroek, B., van Rijssen, E., Joosten, I., & Hilbrands, L. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002711 · Cited by 51
“CD4+CD25+FoxP3+ regulatory T cells (Treg) are involved in maintaining tolerance towards self antigens, and they can regulate alloreactivity as well [8,9].”
BackgroundPeripheral T regulatory cells and cytokines in hepatitis E infection
Tripathy, A. S., Das, R., Rathod, S., Gurav, Y. K., & Arankalle, V. A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1291-1 · Cited by 51
“while this is about 1–2% in whole blood of mice and humans [ 8 , 9]. Tregs can be both beneficial and detrimental to the host during infection [10].”
BackgroundKayser, G., Schulte-Uentrop, L., Sienel, W. G. R., Werner, M., Fisch, P., Passlick, B., Hausen, A. Z., & Stremmel, C. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.01.004 · Cited by 59
“mpairment of tumour immunity, which leads to immunologic tolration of malignant tumours, contributes to the development and rogression of cancer [1–3].”
BackgroundSilica exposure and altered regulation of autoimmunity
Lee, S. P., Matsuzaki, H., Kumagai-Τakei, N., Yoshitome, K., Maeda, M., Chen, Y., Kusaka, M., Urakami, K., Hayashi, H., Fujimoto, W., et al. (2014) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-014-0403-9 · Cited by 51
Kennedy, A., Schmidt, E. M., Cribbs, A. P., Penn, H., Amjadi, P., Syed, K. M., Read, J. E., Green, P. A., Gregory, B., & Brennan, F. M. (2014) · European Journal of Immunology · doi:10.1002/eji.201444453 · Cited by 51
Velthuis, J. H. L., Unger, W. W. J., van der Slik, A. R., Duinkerken, G., Engelse, M. A., Schaapherder, A. F., Ringers, J., van Kooten, C., de Koning, E. J. P., & Roep, B. O. (2008) · Diabetologia · doi:10.1007/s00125-008-1237-z · Cited by 56
“In recent years, several regulatory T cells that contribute to control of allo- and autoreactivity have been characterised: CD4 CD25 forkhead transcription factor P3-positive regulatory T cells [7], IL-10-secreting Tr1 regulatory T cells [8], CD8 CD28 T-suppressor cells [9] and others.”
BackgroundLu, Y. C., Biancotto, A., Cheung, F., Remmers, E. F., Shah, N., McCoy, J. P., & Tsang, J. S. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.025 · Cited by 51
“We next examined this difference together with the expression level of FOXP3, which is a classical marker for delineating so-called ‘‘naturally arising’’ (FOXP3) Treg cells from ‘‘resting memory’’ (FOXP3 ) cells within the larger CD4CD25 subset (Sakaguchi, 2005; Triplett et al., 2012).”
InfluentialA Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy
Guram, K., Kim, S. S., Wu, V. H., Sanders, P. D., Patel, S. H., Schoenberger, S. P., Cohen, E. E. W., Chen, S., & Sharabi, A. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00491 · Cited by 62
Ohno, A., Iwata, T., Katoh, Y., Taniguchi, S., Tanaka, K., Nishio, H., Nakamura, M., Morisada, T., Chen, G., Saito, M., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.07.106 · Cited by 56
Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer
Ouyang, X., Liu, Y., Zhou, Y., Guo, J., Wei, T.-T., Liu, C., Lee, B., Chen, B., Zhang, A., Casey, K. M., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.04.004 · Cited by 54
“Treg-mediated suppression of TAA-reactive T cells has been proposed as a potential mechanism for the failure of some TAA-based cancer vaccines (Sakaguchi, 2005).”
BackgroundAnimal Models of Graves' Hyperthyroidism
Nagayama, Y. (2007) · Thyroid · doi:10.1089/thy.2007.0161 · Cited by 51
FOXP3 gene expression in a tuberculosis case contact study
Burl, S., Hill, P. C., Jeffries, D. J., Holland, M. J., Fox, A., Lugos, M. D., Adegbola, R. A., Rook, G. A. W., Zumla, A. I., Mcadam, K. P. W. J., et al. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03399.x · Cited by 51
Roles of Foxp3 in the occurrence and development of cervical cancer.
Luo, Q., Zhang, S., Wei, H., Pang, X., & Zhang, H. (2015) · PubMed · Cited by 50
CD4+CD25-Foxp3+ T cells: a marker for lupus nephritis?
Bonelli, M. M., Göschl, L., Blüml, S., Karonitsch, T., Steiner, C.-W., Steiner, G. E., Smolen, J. S., & Scheinecker, C. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4553 · Cited by 50
“; licensee BioMed Central Commons Attribution License (http://creativec reproduction in any medium, provided the or for Treg [11-14].”
Battaglia, M., & Roncarolo, M. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.07.007 · Cited by 51
Li, X., Wang, B., Li, Y., Wang, L., Zhao, X., Zhou, X.-B., Guo, Y., Jiang, G., & Yao, C. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.10.059 · Cited by 50
P-Glycoprotein and Drug Resistance in Systemic Autoimmune Diseases
Diamanti, A. P., Rosado, M. M., Scarsella, M., Laganà, B., & D’Amelio, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034965 · Cited by 54
The deviated balance between regulatory T cell and Th17 in autoimmunity
Jadidi‐Niaragh, F., & Mirshafiey, A. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.619987 · Cited by 51
“Hence, high level expression of CD25 (IL-2Rα) and low level of CD127 (IL-7Rα) molecules were introduced as a Treg markers.((20,21)) Some molecules are also suggested as discrimination markers for nTregs such as, cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), l-selectin (CD62L), glucocorticoid induced TNFR (GITR…”
BackgroundMyelin Basic Protein Priming Reduces the Expression of Foxp3 in T Cells via Nitric Oxide
Brahmachari, S., & Pahan, K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0804394 · Cited by 53
Treg‐enriched CD 4+ T cells attenuate collagen synthesis in keloid fibroblasts
Murao, N., Seino, K., Hayashi, T., Ikeda, M., Funayama, E., Furukawa, H., Yamamoto, Y., & Oyama, A. (2014) · Experimental Dermatology · doi:10.1111/exd.12368 · Cited by 57
Utilizing Regulatory T Cells Against Rheumatoid Arthritis
Haque, M. M., Fino, K. K., Lei, F., Xiong, X., & Song, J. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00209 · Cited by 55
“These benefits include: (1) the potential for antigen specificity with the lack of general immunosuppression; (2) the possibility of inducing long-lasting regulation in vivo; and (3) custom-made product that can be designed for each patient, with very limited or absent side effects.”
BackgroundRegulatory T Cells in Atherogenesis
Sasaki, N., Yamashita, T., Takeda, M., & Hirata, K. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10934 · Cited by 55
Liu, M., Zeng, X., Wang, J., Fu, Z., Wang, J., Liu, M., Ren, D., Yu, B., Zheng, L., Hu, X., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0319-y · Cited by 51
“Among T cells subsets, Tregs have a known role in controlling overt inflammation [29].”
BackgroundClinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future
Choudhury, A., Mosolits, S., Kokhaei, P., Hansson, L., Palma, M., & Mellstedt, H. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95005-2 · Cited by 52
The Role of Foxp3+ Regulatory T Cells in Liver Transplant Tolerance
Li, W., Carper, K., Zheng, X. X., Kuhr, C. S., Reyes, J. D., Liang, Y., Perkins, D. L., Thomson, A. W., & Perkins, J. D. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.10.093 · Cited by 50
Immunopathogenesis of IBD: insufficient suppressor function in the gut?
Huibregtse, I. L., van Lent, A. U., & van Deventer, S. J. H. (2006) · Gut · doi:10.1136/gut.2006.103523 · Cited by 62
Verbinnen, B., Billiau, A., Vermeiren, J., Galicia, G., Bullens, D. M. A., Boon, L., Cadot, P., Hens, G., Dewolf-Peeters, C., Gool, S. W. V., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1034 · Cited by 49
“Both naturally occurring (20) and adaptive Treg (21) have been”
BackgroundUp-regulation of Foxp3 participates in progression of cervical cancer
Zeng, C., Yao, Y., Jie, W., Zhang, M., Hu, X., Zhao, Y. D., Wang, S., Yin, J., & Song, Y. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1348-8 · Cited by 49
CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma
Boudousquié, C., Pellaton, C., Barbier, N., & Spertini, F. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03314.x · Cited by 49
Regulatory T-cell directed therapies in liver diseases
Oo, Y. H., & Sakaguchi, S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.034 · Cited by 50
Self-citationSclareol modulates the Treg intra-tumoral infiltrated cell and inhibits tumor growth in vivo
Noori, S., Hassan, Z. M., Mohammadi, M., Habibi, Z., Sohrabi, N., & Bayanolhagh, S. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2010.02.009 · Cited by 49
Huang, H., Ma, Y., Dawicki, W., Zhang, X., & Gordon, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201899 · Cited by 52
“leads to an autoimmune syndrome (34); however, it was since reported that similar depletion of CD4CD25Foxp3 T cells in naive mice also leads to augmented asthma severity following subsequent allergen sensitization (5, 6).”
BackgroundDai, J., Liu, B., Ngoi, S. M., Sun, S., Vella, A. T., & Li, Z. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3219 · Cited by 49
Garbi, N., Hämmerling, G. J., Probst, H. C., & van den Broek, M. F. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.08.007 · Cited by 56
Modulation of T cell responses by IL-2 and IL-2 complexes
Boyman, O., Kolios, A. G. A., & Raeber, M. E. (2015) · PubMed · doi:10.5167/uzh-123113 · Cited by 63
Kobayashi, M., Nakashima, A., Yoshino, O., Masanori, Y., Ushijima, A., Ito, M., Ono, Y., Shima, T., Kawamura, K., Ishizuka, B., et al. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13125 · Cited by 52
Immunomodulatory role of Keratin 76 in oral and gastric cancer
Sequeira, I., Neves, J. F., Carrero, D., Peng, Q., Palasz, N. A., Liakath‐Ali, K., Lord, G. M., Morgan, P. R., Lombardi, G., & Watt, F. M. (2018) · Nature Communications · doi:10.1038/s41467-018-05872-4 · Cited by 54
Xue, M., Liang, H. W., Ji, X., Liu, Y., Ge, Y., Hou, L., & Sun, T. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0392-1 · Cited by 50
Zhao, Z., Wang, Z., Li, Q., Li, W., You, Y., & Zou, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045675 · Cited by 49
Grimbert, P., Mansour, H., Desvaux, D., Roudot-Thoraval, F. O., Audard, V., Dahan, K., Berrehar, F. O., Dehoulle-Poillet, C., Farcet, J., Lang, P., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000248884.71946.19 · Cited by 49
“Foxp3, a gene that encodes a forkhead/winged helix transcription factor Scurfin, is required for T reg cell development and studies support its use as a marker of T reg cells in transplantation (8).”
BackgroundFurset, G., Fløisand, Y., & Sioud, M. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02695.x · Cited by 49
Ma, A., Xiong, Z., Hu, Y., Qi, S., Song, L., Dun, H., Zhang, L., Lou, D., Yang, P., Zhao, Z., et al. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.01.034 · Cited by 49
Jin, O., Kavikondala, S., Mok, M. Y., Sun, L., Gu, J., Fu, R., Chan, A., Yeung, J., Nie, Y., & Lau, C.-S. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3075 · Cited by 49
“Treg cells maintain peripheral tolerance by suppressing the activation and population expansion of self-reactive T cells [32].”
Chauhan, S. K., Saban, D. R., Dohlman, T. H., & Dana, R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203469 · Cited by 49
Alhamarneh, O., Amarnath, S., Stafford, N. D., & Greenman, J. (2008) · Head & Neck · doi:10.1002/hed.20739 · Cited by 58
“When either of these groups is stimulated by antigen, or just T-cell receptor (TCR) and CD28 ligation, they can cause immune suppression, eg, suppress autoimmune disease, tumor immunity, or graft rejection.(34) But these 2 groups of Treg cells differ in their origin and mode of action, as well as their activation requ…”
Chen, L., Yu, Q., Liu, B., & Zhu, L. (2014) · Medical Oncology · doi:10.1007/s12032-014-0374-0 · Cited by 51
“Recently, regulatory T cells (Tregs) and their role in the suppression of antitumoral immune responses have gained increasing attention, and evidence suggests that Tregs can inhibit the generation of host versus tumor immunity in the tumor microenvironment via suppression of tumor-specific effector T-cell responses [3…”
Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis
Jadidi‐Niaragh, F., & Mirshafiey, A. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2010.513391 · Cited by 49
Zhang, X., Li, M., Lian, D., Zheng, X., Zhang, Z., Ichim, T. E., Xia, X., Huang, X., Vladau, C., Suzuki, M., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.013 · Cited by 48
Deng, Z., Cheng, Z., Xiang, X., Yan, J., Zhuang, X., Liu, C., Jiang, H., Ju, S., Zhang, L., Grizzle, W. E., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.023 · Cited by 56
Antimetastatic Activity of a Preventive Cancer Vaccine
Nanni, P., Nicoletti, G., Palladini, A., Croci, S., Murgo, A., Antognoli, A., Landuzzi, L., Fabbi, M., Ferrini, S., Musiani, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2499 · Cited by 48
Restoring regulation – IL-2 therapy in systemic lupus erythematosus
Humrich, J. Y., & Riemekasten, G. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1199957 · Cited by 48
Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases
Abdel-Gadir, A., Massoud, A. H., & Chatila, T. A. (2018) · F1000Research · doi:10.12688/f1000research.12650.1 · Cited by 52
Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes
Alfinito, F., Sica, M., Luciano, L., Pepa, R. D., Palladino, C., Ferrara, I., Giani, U., Ruggiero, G., & Terrazzano, G. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07921.x · Cited by 50
“These cells were observed to express Foxp3 at a percentage >98%, as described (Ahmadzadeh & Rosenberg, 2006).”
BackgroundInfluentialTGF- signaling is required for the function of insulin-reactive T regulatory cells
Du, W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27030 · Cited by 48
“FoxP3, highly expressed in CD4+CD25+ cells, has recently been considered as a master transcription factor for Tregs (17, 52).”
BackgroundAn eye’s view of T regulatory cells
Stein-Streilein, J., & Taylor, A. W. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606383 · Cited by 48
“Although T cells that regulate the immune response may be CD4 or CD8 , the most frequently studied Treg cells are CD4 CD25 cells, which arise naturally within the thymus [16].”
BackgroundPillai, V., & Karandikar, N. J. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.08.012 · Cited by 55
“Natural Tregs have been shown to be anergic in proliferation and cytokine secretion in vitro, but the same may not be true in vivo [33].”
BackgroundCore-specific adaptive regulatory T-cells in different outcomes of hepatitis C
Langhans, B., Braunschweiger, I., Arndt, S., Schulte, W., Satoguina, J., Layland, L. E., Vidovic, N., Hoerauf, A. M., Oldenburg, J., Sauerbruch, T., et al. (2010) · Clinical Science · doi:10.1042/cs20090661 · Cited by 47
Cheng, H.-Y., Gheţu, N., Huang, W.-C., Wang, A. Y. L., Wallace, C. G., Wen, C.-J., Chen, H.-C., Shih, L.-Y., Lin, C.-F., Hwang, S., et al. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.06.020 · Cited by 49
Liu, X.-J., Zhang, J.-F., Sun, B., Peng, H.-S., Kong, Q.-F., Bai, S.-S., Liu, Y.-M., Wang, G. ‐., Wang, J.-H., & Li, H.-L. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03995.x · Cited by 47
Guo, D., Liu, X., Zeng, C., Cheng, L., Song, G., Hou, X., Zhu, L., & Zou, K. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105971 · Cited by 51
Estradiol-dependent perforin expression by human regulatory T-cells
Valor, L., Teijeiro, R., Aristimuño, C., Faure, F., Alonso, B., de Andrés, C., Tejera, M., Lazareno, N. L., Fernández‐Cruz, E., & Sánchez‐Ramón, S. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02414.x · Cited by 47
Lau-Kilby, A. W., Biester, S., Cornall, R. J., & Forrester, J. V. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3889 · Cited by 51
“Tregs come in various functional phenotypes, the most well studied being the CD4 CD25 Foxp3 T cell (1, 2).”
BackgroundPreferential Development of CD4 and CD8 T Regulatory Cells in RasGRP1-Deficient Mice
Chen, X., Priatel, J. J., Chow, M., & Teh, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5973 · Cited by 47
“Three main cell types have been considered as potential Treg cell subsets, as follows: CD4 CD25 Treg cells (5, 6), CD8 intestinal epithelial lymphocytes (7), and NKT cells (3).”
BackgroundIn vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules
Nishioka, T., Nishida, E., Iida, R., Morita, A., & Shimizu, J. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.09.003 · Cited by 47
Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis
Aristimuño, C., Teijeiro, R., Valor, L., Alonso, B., Tejera‐Alhambra, M., de Andrés, C., Oliver‐Miñarro, D., Lazareno, N. L., Faure, F., & Sánchez‐Ramón, S. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-011-0172-3 · Cited by 50
“factor, FoxP3 [15–17].”
BackgroundAnti-CD25 mAb Administration Prevents Spontaneous Liver Transplant Tolerance
Li, W., Carper, K., Liang, Y., Zheng, X. X., Kuhr, C. S., Reyes, J. D., Perkins, D. L., Thomson, A. W., & Perkins, J. D. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.10.094 · Cited by 47
Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis
Haas, J., Schopp, L., Storch-Hagenlocher, B., Fritzsching, B., Jacobi, C., Milkova, L., Fritz, B., Schwarz, A., Suri‐Payer, E., Hensel, M., et al. (2007) · Blood · doi:10.1182/blood-2007-08-104877 · Cited by 47
“CSF cells were first gated according to forward- and side light-scattering properties and CD4-expression and then analyzed for expression of CD25 and FOXP3 as only CD4 T-cells expressing the FOXP3 gene product scurfin exhibit suppressive function.(27) Treg numbers were defined as the proportion of CD25FOXP3 cells amon…”
Roles of CD4+CD25high FOXP3+ Tregs in lymphomas and tumors are complex
Ke, X., Wang, J., Li, L., Chen, I.-L., Wang, H., & Yang, X. (2008) · Frontiers in bioscience · doi:10.2741/2986 · Cited by 55
“cells (20), and CD3+CD4-CD8-αβTCR+ T cells (23) have been reported, among which CD4+CD25FOXP3+ regulatory T cells (Tregs) are best characterized (24-28).”
BackgroundSilencing T cells or T-cell silencing: concepts in virus-induced immunosuppression
Schneider‐Schaulies, S., & Dittmer, U. (2006) · Journal of General Virology · doi:10.1099/vir.0.81713-0 · Cited by 47
“During chronic FV infection, more the 70 % of the CD4+ GITR+ or CD4+ CD103+ T-cell populations were also positive for the Treg-cell-specific transcription factor Foxp3 (Sakaguchi, 2005), implying that these cells do indeed perform regulatory functions (G. Zelinskyy and U. Dittmer, submitted).”
BackgroundElkhal, A., Rodriguez Cetina Biefer, H., Heinbokel, T., Uehara, H., Quante, M., Seyda, M., Schuitenmaker, J. M., Krenzien, F., Camacho, V., de la Fuente, M. A., et al. (2016) · Scientific Reports · doi:10.1038/srep22325 · Cited by 46
The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome
Lai, R., Nakiwala, J. K., Meintjes, G., & Wilkinson, R. J. (2013) · European Journal of Immunology · doi:10.1002/eji.201343632 · Cited by 56
Muth, S., Schütze, K., Schild, H., & Probst, H. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110620109 · Cited by 46
Vetsika, E., Konsolakis, G., Aggouraki, D., Kotsakis, A. P., Papadimitraki, E., Christou, S., Menez-Jamet, J., Kosmatopoulos, K., Georgoulias, V., & Mavroudis, D. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1093-4 · Cited by 46
Brusko, T. M., & Atkinson, M. A. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0018-5 · Cited by 51
“Since the findings of Sakaguchi reporting multi-organ autoimmunity of mice subjected to thymectomy in early life, multiple studies have suggested that CD4CD25 regulatory T cells function as major regulators of the immune response and impact the development of autoimmunity [7, 34, 35].”
BackgroundHeat shock proteins (HSPs) in the homeostasis of regulatory T cells (Tregs)
Koliński, T., Marek-Trzonkowska, N. M., Trzonkowski, P., & Siebert, J. (2016) · Central European Journal of Immunology · doi:10.5114/ceji.2016.63133 · Cited by 46
“Basic suppressive mechanisms used by Tregs are: 1) secretion of anti-inflammatory cytokines such as: transforming growth factor beta (TGF-β), interleukin (IL) 10, and IL-35 [6], 2) killing of target cells in granzyme and perforin dependent fashion [9], 3) suppression of dendritic cell (DC) maturation, 4) induction of…”
BackgroundCellular Metabolic Regulation in the Differentiation and Function of Regulatory T Cells
Chen, Y., Colello, J., Jarjour, W. N., & Zheng, S. G. (2019) · Cells · doi:10.3390/cells8020188 · Cited by 52
“We confirmed, along with several groups, that IL-2 is still necessary to induce and expand Tregs [10,85].”
ResultNovel Functions of RANK(L) Signaling in the Immune System
Leibbrandt, A., & Penninger, J. M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1050-9_9 · Cited by 53
“Significantly, the binding of denosumab to RANKL is selective, and Denosumab does not show any signs of cross-reactivity to TNF-α ,T NF-β, CD40L, or TRAIL [ 82 ].”
BackgroundDysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis
Lewkowicz, N., Lewkowicz, P., Dzitko, K., Kur, B., Tarkowski, M., Kurnatowska, A. J., & Tchórzewski, H. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2008.00661.x · Cited by 46
“of anti-inflammatory cytokines have been implicated as well as granzyme ⁄ perforin-dependent mechanism of cytotoxic activity (11, 12).”
BackgroundT Helper Cell Polarization in Healthy People: Implications for Cardiovascular Disease
Olson, N. C., Sallam, R. M., Doyle, M. F., Tracy, R. P., & Huber, S. A. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9496-6 · Cited by 50
O’Connor, R. A., Taams, L. S., & Anderton, S. M. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04040.x · Cited by 50
Holmes, D., Knudsen, G. T., Mackey-Cushman, S., & Su, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702051200 · Cited by 52
Transcriptional basis of lymphocyte tolerance
Borde, M., Barrington, R. A., Heissmeyer, V., Carroll, M. C., & Rao, A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00370.x · Cited by 50
Ma, A., Qi, S., Song, L., Hu, Y., Dun, H., Massicotte, E., Dupuis, M., Daloze, P., & Chen, H. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.001 · Cited by 48
Immunobiology of Herpes Simplex Virus and Cytomegalovirus Infections of the Fetus and Newborn
Muller, W. J., Jones, C., & Koelle, D. M. (2010) · Current Immunology Reviews · doi:10.2174/157339510790231833 · Cited by 48
“CD4 + T-cells involved in establishing and maintaining immunologic tolerance [270].”
BackgroundComplement regulates inhalation tolerance at the dendritic cell/T cell interface
Köhl, J., & Wills-Karp, M. A. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.016 · Cited by 49
Kamaté, C., Lenting, P. J., van den Berg, H. M., & Mutis, T. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02336.x · Cited by 46
New Approaches to Immunotherapy for HPV Associated Cancers
Bergot, A., Kassianos, A. J., Frazer, I. H., & Mittal, D. (2011) · Cancers · doi:10.3390/cancers3033461 · Cited by 56
“mice [44,45].”
Metadata
- Authors
- Sakaguchi, S.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- ORCID
- Sakaguchi, Shimon
- Venue
- Nature Immunology
- Published
- 2005-03-22
- Volume
- 6
- Issue
- 4
- Pages
- 345-352
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2004708987
- Cited by
- 2,669
- References
- 109
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 39 · 2023: 54 · 2022: 59 · 2021: 68 · 2020: 68 · 2019: 84 · 2018: 83 · 2017: 92 · 2016: 98 · 2015: 113 · 2014: 127 · 2013: 148 · 2012: 169
- FWCI
- 22.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Foxp3, regulatory T cells, CD4+CD25+ T cells, immune tolerance, self-tolerance, autoimmune disease, antitumor immunity, transplantation tolerance, antigen-specific T cell expansion, immunomodulation
- MeSH terms
- Animals, Antigens, Differentiation, Autoimmune Diseases, DNA-Binding Proteins, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Thymus Gland, Transplantation Immunology, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Self Tolerance, Forkhead Transcription Factors, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.